Divis Laboratories Ltd | DIVI - Equity Capital And Reserves



Divis Laboratories Ltd reported 149.69B in Equity Capital and Reserves for its fiscal quarter ending in March of 2025.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
Aurobindo Pharma INR 326.53B 17.75B Mar/2025
Avita Medical AUD 4.5M 19.42M Dec/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Divis Laboratories Ltd 149.69B 12.52B Mar/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
Lupin INR 172.04B 15.62B Mar/2025
Moderna USD 9.4B 667M Jun/2025
Organon & Co USD 733M 191M Jun/2025
Revvity USD 7.64B 29.74M Mar/2025
Tectonic Therapeutic USD 283.77M 142.99M Jun/2025
Tilray USD 3.47B 5.16M Nov/2024
Viatris USD 15.57B 79.9M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025